Search

Find exactly what you’re looking for.
Search

Service
Insights
Showing 1-20 of 38 results

This checklist highlights certain considerations for companies preparing to file annual reports on Form 10-K for the calendar year ended 2023 and is intended to serve as a focused resource highlighting changes in disclosure requirements and points of emphasis for the Securities and Exchange...

​This issue of Saul on ESG: Trends & Updates marks our first update tracking the legal trends and developments around environmental, social and governance (ESG). In recent years, we have been tracking and highlighting changes on the ESG front, but this regular publication will allow us to dive...

Saul Ewing Partners Andy Bockis, Justin Danilewitz and Sean O'Neill will speak at the 2022 Oil & Gas Law Conference on October 26, 2022. Their topic will be "Will the SEC's Proposed Climate Reporting Rules Survive a Major Questions Challenge."

The law firm of Saul Ewing invites you to their 7th Biennial Energy and the Environment Symposium in Houston, Texas. This half-day hybrid MCLE brought together in-house counsel, prominent industry representatives and government officials - virtually and in-person - to share their insights on the...

Sean T. O'Neill

Sean O'Neill handles commercial and real estate litigation matters for energy companies, developers, higher education institutions and insurance companies, among others. He also advises clients on environmental social and governance (ESG) related issues and provides counsel in connection with...

Companies planning to develop and commercialize medical devices or diagnostics face a challenging financing, regulatory, reimbursement and liability environment. Saul Ewing attorneys are experienced in helping medical device and diagnostic companies navigate these challenges. Many members of our...

Jessica Lenoir

Jessica Lenoir, Ph.D., helps clients protect their intellectual property by drafting patent applications and preparing office action responses to the U.S. Patent and Trademark Office and foreign offices. In handling this work, Jessica draws on her knowledge from earning a doctorate in...

John P. Englert

John P. Englert has almost 40 years of diverse environmental experience. Since 1994 John has practiced environmental law and before that he was an environmental consultant. In both capacities, he has served national and international companies in the energy, environmental and manufacturing sectors...

The pharmaceutical industry faces a challenging business environment as competition drives down prices, R&D expenses rise, and government scrutiny deepens. However, companies have many options for navigating these challenges, generally by making deals with others in the field, including mergers and...

Tom Murray, Ph.D.

Tom Murray is a patent agent who helps clients protect their intellectual property through patent preparation and prosecution, as well as analyses involving freedom to operate, non-infringement and invalidity. Tom also has experience with matters involving post-grant prosecutions. His IP work for...

Despite the challenges of transmission and grid interconnection, the U.S. has become one of the fastest-growing wind markets in the world. Saul Ewing attorneys advise a variety of clients in this industry, including wind power developers, owners and users, power companies, electric utility companies...

Andrew Schwerin

Andrew Schwerin represents clients in patent and trade secret litigation on both the plaintiff and defense sides of these disputes. Outside of his litigation work, Andrew counsels clients on their IP strategy. Andrew has represented clients in connection with a range of technologies including...

Michelle C. Streifthau-Livizos

Michelle Streifthau-Livizos represents clients in litigation matters, including disputes involving the Hatch-Waxman Act, patents, copyrights and trademarks. She handles cases involving various types of technology, including representations of pharmaceutical companies, life sciences companies...

Lukas Pfannenstiel

Lukas Pfannenstiel draws on his scientific background to assist clients in protecting their intellectual property. Lukas has a Ph.D. in cellular and molecular medicine from Johns Hopkins University School of Medicine, a bachelor's degree in cell biology from University of Kansas, and practical...

Sean P. Ritchie

Sean Ritchie advises clients on how to protect their intellectual property and assists them in doing so by drafting, filing, prosecuting and enforcing patents and trademarks. He also counsels on the patentability of their IP and on patent infringement issues, and litigates these issues when needed...

Matthew D. Kohel

Matt Kohel represents clients in commercial litigation, intellectual property matters, and data privacy issues. Clients in an array of industries rely on Matt to protect their interests in courts across the United States and in arbitrations on matters involving allegations of breach of contract...

Joseph Kuo

Joseph Kuo's practice encompasses a broad range of experience in intellectual property law, including patents, trademarks, unfair competition, copyrights, false advertising, and trade secrets. Joseph has counseled a wide array of clients ranging from large established companies, to young start-up...

Yogini Bhavsar Headshot

Yogini Bhavsar-Jog (Ph.D.) focuses on drafting and prosecuting patents in the areas including biochemistry, molecular biology, pharmaceuticals, biologics, nanotechnology, physics, chemical engineering and medical devices. In addition to the United States, Yogini is involved in managing prosecution...

Valerie L. O'Shea Murray

Valerie O'Shea Murray, Ph.D., is a registered patent agent who prepares and prosecutes patent applications in a broad spectrum of technology areas, including biotechnology, immunology, chemistry, and life sciences. Valerie's intellectual property experience includes work for a variety of clients...

Protecting patents and maximizing their value are paramount to the success of brand pharmaceutical companies and university technology departments, in particular as they relate to generic competitors who file Abbreviated New Drug Applications (ANDAs) under the Hatch-Waxman Act. Saul Ewing’s...

For More Information
Contact us